ArticleClinical case reports2025
Obstructive Ureteral Metastasis From Prostate Cancer.
Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Fibroepithelial Polyp of the Proximal Ureter Presenting as Chronic Hematuria and Hydronephrosis in an Adolescent: A Case Report.Research and reports in urology · 2026Article
- Obstructive Ureteral Metastasis From Prostate Cancer.Clinical case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prostate cancer is the second most common malignancy in males, primarily associated with risk factors such as age, ethnicity, obesity, and family history. While metastases commonly involve lymph nodes, bones, and the liver, ureteral metastasis is exceedingly rare. Ureteral obstruction due to metastatic prostate cancer can lead to hydronephrosis, often requiring ureteroscopy for diagnosis and management. However, persistent symptoms may necessitate exploratory surgery. An 82-year-old Arab male with a history of Gleason 4 + 4 = 8 prostate adenocarcinoma (initially managed with hormonal therapy and surgical castration) presented with right back pain. Imaging revealed stage 4 hydronephrosis, initially attributed to a ureteral stone. Ureteroscopy identified obstructing ureteral tumors instead, with biopsy confirming well-differentiated adenocarcinoma of prostatic origin. Due to persistent obstruction and confirmed malignancy, a right nephroureterectomy was performed. Histopathology demonstrated extensive ureteral involvement (16 cm) with vascular and perineural invasion but no distant metastasis on postoperative PET-CT. This case underscores the diagnostic challenge of ureteral metastasis in prostate cancer, often mimicking benign conditions like ureteral stones. Despite successful local surgical control, the tumor's aggressive features necessitate long-term surveillance and continued hormonal therapy. High clinical suspicion for metastasis is crucial in high-risk prostate cancer patients presenting with obstructive uropathy, even in the absence of significantly elevated PSA. This report highlights the importance of a stepwise diagnostic approach and the need for prompt intervention in such rare presentations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.